{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:02:34Z","timestamp":1790683354032,"version":"4.1.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s40744-026-00877-8","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T17:37:53Z","timestamp":1787247473000},"page":"1203-1221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fertility and Birth Outcomes in Rheumatoid Arthritis: A Narrative Review"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6570-1082","authenticated-orcid":false,"given":"Noel L.","family":"Ermer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2387-5363","authenticated-orcid":false,"given":"Lisa R.","family":"Sammaritano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6057-0070","authenticated-orcid":false,"given":"Caroline H.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"877_CR1","doi-asserted-by":"publisher","first-page":"10736","DOI":"10.1038\/s41598-025-92150-1","volume":"15","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Gao X, Liu S, et al. Global, regional, and national epidemiology of rheumatoid arthritis among people aged 20\u201354 years from 1990 to 2021. Sci Rep. 2025;15:10736. https:\/\/doi.org\/10.1038\/s41598-025-92150-1.","journal-title":"Sci Rep"},{"key":"877_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1056\/NEJMra2103726","volume":"388","author":"EM Gravallese","year":"2023","unstructured":"Gravallese EM, Firestein GS. Rheumatoid arthritis\u2014common origins, divergent mechanisms. N Engl J Med. 2023;388:529\u201342. https:\/\/doi.org\/10.1056\/NEJMra2103726.","journal-title":"N Engl J Med"},{"key":"877_CR3","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","volume":"5","author":"RJ Black","year":"2023","unstructured":"Black RJ, Cross M, Haile LM, et al. Global, regional, and national burden of rheumatoid arthritis, 1990\u20132020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5:e594\u2013610. https:\/\/doi.org\/10.1016\/S2665-9913(23)00211-4.","journal-title":"Lancet Rheumatol"},{"key":"877_CR4","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/acr.21593","volume":"64","author":"MEB Clowse","year":"2012","unstructured":"Clowse MEB, Chakravarty E, Costenbader KH, Chambers C, Michaud K. Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2012;64:668\u201374. https:\/\/doi.org\/10.1002\/acr.21593.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"877_CR5","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1002\/acr.23124","volume":"69","author":"J Brouwer","year":"2017","unstructured":"Brouwer J, Fleurbaaij R, Hazes JMW, Dolhain RJEM, Laven JSE. Subfertility in women with rheumatoid arthritis and the outcome of fertility assessments. Arthritis Care Res (Hoboken). 2017;69:1142\u20139. https:\/\/doi.org\/10.1002\/acr.23124.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"877_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-059203","volume":"12","author":"Y-C Tsai","year":"2022","unstructured":"Tsai Y-C, Chang H-C, Chiou M-J, Luo S-F, Kuo C-F. Fetal\u2013neonatal and maternal pregnancy outcomes in women with rheumatoid arthritis: a population-based cohort study. BMJ Open. 2022;12:e059203. https:\/\/doi.org\/10.1136\/bmjopen-2021-059203.","journal-title":"BMJ Open"},{"key":"877_CR7","doi-asserted-by":"publisher","unstructured":"Vegas LP, Drouin J, Weill A, Dray-Spira R. Pregnancy outcomes in women with rheumatoid arthritis: an 11-year French nationwide study. RMD Open. 2024;10(1):e003762. https:\/\/doi.org\/10.1136\/rmdopen-2023-003762.","DOI":"10.1136\/rmdopen-2023-003762"},{"key":"877_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-023-06033-2","volume":"23","author":"J Lv","year":"2023","unstructured":"Lv J, Xu L, Mao S. Association between disease activity of rheumatoid arthritis and maternal and fetal outcomes in pregnant women: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2023;23:724. https:\/\/doi.org\/10.1186\/s12884-023-06033-2.","journal-title":"BMC Pregnancy Childbirth"},{"key":"877_CR9","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s10067-022-06436-0","volume":"42","author":"W Huang","year":"2023","unstructured":"Huang W, Wu T, Jin T, et al. Maternal and fetal outcomes in pregnant women with rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol. 2023;42:855\u201370. https:\/\/doi.org\/10.1007\/s10067-022-06436-0.","journal-title":"Clin Rheumatol"},{"key":"877_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/RHU.0000000000001935","volume":"29","author":"BL Sim","year":"2023","unstructured":"Sim BL, Daniel RS, Hong SS, et al. Pregnancy outcomes in women with rheumatoid arthritis: a systematic review and meta-analysis. J Clin Rheumatol. 2023;29:36. https:\/\/doi.org\/10.1097\/RHU.0000000000001935.","journal-title":"J Clin Rheumatol"},{"key":"877_CR11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/acr.24130","volume":"72","author":"LR Sammaritano","year":"2020","unstructured":"Sammaritano LR, Bermas BL, Chakravarty EE, et al. 2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Care Res (Hoboken). 2020;72:461\u201388. https:\/\/doi.org\/10.1002\/acr.24130.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"877_CR12","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ard.2025.02.023","volume":"84","author":"L R\u00fcegg","year":"2025","unstructured":"R\u00fcegg L, Pluma A, Hamroun S, et al. EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update. Ann Rheum Dis. 2025;84:910\u201326. https:\/\/doi.org\/10.1016\/j.ard.2025.02.023.","journal-title":"Ann Rheum Dis"},{"key":"877_CR13","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1136\/annrheumdis-2021-220709","volume":"80","author":"LF Perez-Garcia","year":"2021","unstructured":"Perez-Garcia LF, R\u00f6der E, Goekoop RJ, et al. Impaired fertility in men diagnosed with inflammatory arthritis: results of a large multicentre study (iFAME-Fertility). Ann Rheum Dis. 2021;80:1545\u201352. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220709.","journal-title":"Ann Rheum Dis"},{"key":"877_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1136\/ard-2023-224998","volume":"83","author":"GD Sigmo","year":"2024","unstructured":"Sigmo GD, Hauge S, Hufthammer KO, et al. Male patients with inflammatory joint diseases are less likely than controls to be childless: results from a Norwegian population-based cohort study of 10 865 patients. Ann Rheum Dis. 2024;83:457\u201363. https:\/\/doi.org\/10.1136\/ard-2023-224998.","journal-title":"Ann Rheum Dis"},{"key":"877_CR15","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/humrep\/deh870","volume":"20","author":"C Gnoth","year":"2005","unstructured":"Gnoth C, Godehardt E, Frank-Herrmann P, Friol K, Tigges J, Freundl G. Definition and prevalence of subfertility and infertility. Hum Reprod. 2005;20:1144\u20137. https:\/\/doi.org\/10.1093\/humrep\/deh870.","journal-title":"Hum Reprod"},{"key":"877_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.2021.4788","volume":"326","author":"SA Carson","year":"2021","unstructured":"Carson SA, Kallen AN. Diagnosis and management of infertility. JAMA. 2021;326:65\u201376. https:\/\/doi.org\/10.1001\/jama.2021.4788.","journal-title":"JAMA"},{"key":"877_CR17","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/rheumatology\/keq458","volume":"50","author":"M Wallenius","year":"2011","unstructured":"Wallenius M, Skomsvoll JF, Irgens LM, et al. Fertility in women with chronic inflammatory arthritides. Rheumatology (Oxford). 2011;50:1162\u20137. https:\/\/doi.org\/10.1093\/rheumatology\/keq458.","journal-title":"Rheumatology (Oxford)"},{"key":"877_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/acr2.11043","volume":"1","author":"J Brouwer","year":"2019","unstructured":"Brouwer J, Dolhain RJEM, Hazes JMW, Visser JA, Laven JSE. Reduced ovarian function in female rheumatoid arthritis patients trying to conceive. ACR Open Rheumatol. 2019;1:327\u201335. https:\/\/doi.org\/10.1002\/acr2.11043.","journal-title":"ACR Open Rheumatol"},{"key":"877_CR19","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1136\/annrheumdis-2014-205383","volume":"74","author":"J Brouwer","year":"2015","unstructured":"Brouwer J, Hazes JMW, Laven JSE, Dolhain RJEM. Fertility in women with rheumatoid arthritis: influence of disease activity and medication. Ann Rheum Dis. 2015;74:1836\u201341. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205383.","journal-title":"Ann Rheum Dis"},{"key":"877_CR20","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1093\/jsxmed\/qdae114","volume":"21","author":"J Huang","year":"2024","unstructured":"Huang J, Guo C, Sun J, Hua R, Fan Y. Prevalence and risk factors of sexual dysfunction in female participants with rheumatoid arthritis: a systematic review and meta-analysis. J Sex Med. 2024;21:1037\u201346. https:\/\/doi.org\/10.1093\/jsxmed\/qdae114.","journal-title":"J Sex Med"},{"key":"877_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s40744-023-00634-1","volume":"11","author":"P-F Li","year":"2024","unstructured":"Li P-F, Li S, Zheng P-S. Reproductive effect by rheumatoid arthritis and related autoantibodies. Rheumatol Ther. 2024;11:239\u201356. https:\/\/doi.org\/10.1007\/s40744-023-00634-1.","journal-title":"Rheumatol Ther"},{"key":"877_CR22","doi-asserted-by":"publisher","unstructured":"Brouwer J, Dolhain RJEM, Hazes JMW, Erler NS, Visser JA, Laven JSE. Decline of ovarian function in patients with rheumatoid arthritis: serum anti-M\u00fcllerian hormone levels in a longitudinal cohort. RMD Open. 2020;6(3):e001307. https:\/\/doi.org\/10.1136\/rmdopen-2020-001307.","DOI":"10.1136\/rmdopen-2020-001307"},{"key":"877_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2023.104152","volume":"160","author":"C Huang","year":"2023","unstructured":"Huang C, AlSubki L, Yamaya A, Sung N, Kwak-Kim J. Poor ovarian response in assisted reproductive technology cycles is associated with anti-ovarian antibody and pro-inflammatory immune responses. J Reprod Immunol. 2023;160:104152. https:\/\/doi.org\/10.1016\/j.jri.2023.104152.","journal-title":"J Reprod Immunol"},{"key":"877_CR24","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/aji.12038","volume":"69","author":"M Van Sinderen","year":"2013","unstructured":"Van Sinderen M, Menkhorst E, Winship A, Cuman C, Dimitriadis E. Preimplantation human blastocyst-endometrial interactions: the role of inflammatory mediators. Am J Reprod Immunol. 2013;69:427\u201340. https:\/\/doi.org\/10.1111\/aji.12038.","journal-title":"Am J Reprod Immunol"},{"key":"877_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.604866","volume":"11","author":"M Bongenaar","year":"2020","unstructured":"Bongenaar M, Smeele HTW, Lubberts E, Dolhain RJEM. IL-6 but not TNF\u03b1 levels are associated with time to pregnancy in female rheumatoid arthritis patients with a wish to conceive. Front Pharmacol. 2020;11:604866. https:\/\/doi.org\/10.3389\/fphar.2020.604866.","journal-title":"Front Pharmacol"},{"key":"877_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2025-005770","author":"GD Sigmo","year":"2025","unstructured":"Sigmo GD, Hauge S, Hetland HB, et al. Men with psoriatic arthritis, rheumatoid arthritis and axial spondylarthritis have more children and at an earlier age than matched controls: results from a nationwide cohort. RMD Open. 2025. https:\/\/doi.org\/10.1136\/rmdopen-2025-005770.","journal-title":"RMD Open"},{"key":"877_CR27","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3899\/jrheum.080558","volume":"36","author":"B Tengstrand","year":"2009","unstructured":"Tengstrand B, Carlstr\u00f6m K, Hafstr\u00f6m I. Gonadal hormones in men with rheumatoid arthritis\u2014from onset through 2 years. J Rheumatol. 2009;36:887\u201392. https:\/\/doi.org\/10.3899\/jrheum.080558.","journal-title":"J Rheumatol"},{"key":"877_CR28","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/oxfordjournals.qjmed.a068024","volume":"60","author":"D Gordon","year":"1986","unstructured":"Gordon D, Beastall GH, Thomson JA, Sturrock RD. Androgenic status and sexual function in males with rheumatoid arthritis and ankylosing spondylitis. Q J Med. 1986;60:671\u20139.","journal-title":"Q J Med"},{"key":"877_CR29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1600-0897.2008.00676.x","volume":"61","author":"Y Shiraishi","year":"2009","unstructured":"Shiraishi Y, Shibahara H, Koriyama J, et al. Original article: incidence of antisperm antibodies in males with systemic autoimmune diseases. Am J Reprod Immunol. 2009;61:183\u20139. https:\/\/doi.org\/10.1111\/j.1600-0897.2008.00676.x.","journal-title":"Am J Reprod Immunol"},{"key":"877_CR30","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1093\/rheumatology\/39.8.880","volume":"39","author":"LL Mendon\u00e7a","year":"2000","unstructured":"Mendon\u00e7a LL, Khamashta MA, Nelson-Piercy C, Hunt BJ, Hughes GR. Non-steroidal anti-inflammatory drugs as a possible cause for reversible infertility. Rheumatology (Oxford). 2000;39:880\u20132. https:\/\/doi.org\/10.1093\/rheumatology\/39.8.880.","journal-title":"Rheumatology (Oxford)"},{"key":"877_CR31","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/acr.20510","volume":"63","author":"MC Micu","year":"2011","unstructured":"Micu MC, Micu R, Ostensen M. Luteinized unruptured follicle syndrome increased by inactive disease and selective cyclooxygenase 2 inhibitors in women with inflammatory arthropathies. Arthritis Care Res (Hoboken). 2011;63:1334\u20138. https:\/\/doi.org\/10.1002\/acr.20510.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"877_CR32","first-page":"109","volume":"35","author":"S Whirledge","year":"2010","unstructured":"Whirledge S, Cidlowski JA. Glucocorticoids, stress, and fertility. Minerva Endocrinol. 2010;35:109\u201325.","journal-title":"Minerva Endocrinol"},{"key":"877_CR33","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1093\/humrep\/dey322","volume":"33","author":"Q-N Li","year":"2018","unstructured":"Li Q-N, Li L, Hou G, et al. Glucocorticoid exposure affects female fertility by exerting its effect on the uterus but not on the oocyte: lessons from a hypercortisolism mouse model. Hum Reprod. 2018;33:2285\u201394. https:\/\/doi.org\/10.1093\/humrep\/dey322.","journal-title":"Hum Reprod"},{"key":"877_CR34","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/toxsci\/kfj036","volume":"89","author":"JG Affleck","year":"2006","unstructured":"Affleck JG, Neumann K, Wong L, Walker VK. The effects of methotrexate on Drosophila development, female fecundity, and gene expression. Toxicol Sci. 2006;89:495\u2013503. https:\/\/doi.org\/10.1093\/toxsci\/kfj036.","journal-title":"Toxicol Sci"},{"key":"877_CR35","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1002\/acr.22013","volume":"65","author":"J Brouwer","year":"2013","unstructured":"Brouwer J, Laven JSE, Hazes JMW, Schipper I, Dolhain RJEM. Levels of serum anti-M\u00fcllerian hormone, a marker for ovarian reserve, in women with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2013;65:1534\u20138. https:\/\/doi.org\/10.1002\/acr.22013.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"877_CR36","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.fertnstert.2023.05.005","volume":"120","author":"P Zar\u00e9n","year":"2023","unstructured":"Zar\u00e9n P, Turesson C, Giwercman A. Methotrexate use among men\u2014association with fertility and the perinatal health of their children: a Swedish nationwide register study. Fertil Steril. 2023;120:661\u20139. https:\/\/doi.org\/10.1016\/j.fertnstert.2023.05.005.","journal-title":"Fertil Steril"},{"key":"877_CR37","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/andr.12366","volume":"5","author":"M Semet","year":"2017","unstructured":"Semet M, Paci M, Sa\u00efas-Magnan J, Metzler-Guillemain C, Boissier R, Lejeune H, et al. The impact of drugs on male fertility: a review. Andrology. 2017;5:640\u201363. https:\/\/doi.org\/10.1111\/andr.12366.","journal-title":"Andrology"},{"key":"877_CR38","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1136\/ard-2023-224032","volume":"82","author":"LF Perez-Garcia","year":"2023","unstructured":"Perez-Garcia LF, R\u00f6der E, Krijthe BP, et al. Is methotrexate safe for men with an immune-mediated inflammatory disease and an active desire to become a father? Results of a prospective cohort study (iFAME-MTX). Ann Rheum Dis. 2023;82:1068\u201375. https:\/\/doi.org\/10.1136\/ard-2023-224032.","journal-title":"Ann Rheum Dis"},{"key":"877_CR39","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S0022-5347(17)49824-7","volume":"132","author":"MJ Cosentino","year":"1984","unstructured":"Cosentino MJ, Chey WY, Takihara H, Cockett ATK. The effects of sulfasalazine on human male fertility potential and seminal prostaglandins. J Urol. 1984;132:682\u20136. https:\/\/doi.org\/10.1016\/S0022-5347(17)49824-7.","journal-title":"J Urol"},{"key":"877_CR40","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s10067-019-04450-3","volume":"38","author":"H Shimada","year":"2019","unstructured":"Shimada H, Kameda T, Kanenishi K, et al. Effect of biologic disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis who hope to become mothers. Clin Rheumatol. 2019;38:1453\u20138. https:\/\/doi.org\/10.1007\/s10067-019-04450-3.","journal-title":"Clin Rheumatol"},{"key":"877_CR41","doi-asserted-by":"publisher","unstructured":"Quaak CH, R\u00f6der E, Wintjes HM, et al. Time to pregnancy in women with rheumatoid arthritis who want to conceive treated according to a treat-to-target approach: a comparison of an observational cohort with a historical reference cohort. Lancet Rheumatol. 2026;8(6):e461\u20139. https:\/\/doi.org\/10.1016\/S2665-9913(26)00001-9.","DOI":"10.1016\/S2665-9913(26)00001-9"},{"key":"877_CR42","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.semarthrit.2018.07.011","volume":"48","author":"M Mouyis","year":"2019","unstructured":"Mouyis M, Flint JD, Giles IP. Safety of anti-rheumatic drugs in men trying to conceive: a systematic review and analysis of published evidence. Semin Arthritis Rheum. 2019;48:911\u201320. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.07.011.","journal-title":"Semin Arthritis Rheum"},{"key":"877_CR43","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1080\/14397595.2019.1661592","volume":"30","author":"S Tsuda","year":"2020","unstructured":"Tsuda S, Sameshima A, Sekine M, et al. Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: multi-center retrospective descriptive study. Mod Rheumatol. 2020;30:852\u201361. https:\/\/doi.org\/10.1080\/14397595.2019.1661592.","journal-title":"Mod Rheumatol"},{"key":"877_CR44","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1093\/humrep\/deh304","volume":"19","author":"H Leridon","year":"2004","unstructured":"Leridon H. Can assisted reproduction technology compensate for the natural decline in fertility with age? A model assessment. Hum Reprod. 2004;19:1548\u201353. https:\/\/doi.org\/10.1093\/humrep\/deh304.","journal-title":"Hum Reprod"},{"key":"877_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02704-7","volume":"24","author":"N Rebi\u0107","year":"2022","unstructured":"Rebi\u0107 N, Munro S, Garg R, et al. \u201cThe medications are the decision-makers\u2026\u201d Making reproductive and medication use decisions among female patients with rheumatoid arthritis: a constructivist grounded theory. Arthritis Res Ther. 2022;24:31. https:\/\/doi.org\/10.1186\/s13075-021-02704-7.","journal-title":"Arthritis Res Ther"},{"key":"877_CR46","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5312\/wjo.v5.i2.107","volume":"5","author":"AG Tristano","year":"2014","unstructured":"Tristano AG. Impact of rheumatoid arthritis on sexual function. World J Orthop. 2014;5:107\u201311. https:\/\/doi.org\/10.5312\/wjo.v5.i2.107.","journal-title":"World J Orthop"},{"key":"877_CR47","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3899\/jrheum.170956","volume":"45","author":"S Zhao","year":"2018","unstructured":"Zhao S, Li E, Wang J, Luo L, Luo J, Zhao Z. Rheumatoid arthritis and risk of sexual dysfunction: a systematic review and metaanalysis. J Rheumatol. 2018;45:1375\u201382. https:\/\/doi.org\/10.3899\/jrheum.170956.","journal-title":"J Rheumatol"},{"key":"877_CR48","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejogrb.2020.05.068","volume":"251","author":"M Bourg","year":"2020","unstructured":"Bourg M, Ruyssen-Witrand A, Bettiol C, Parinaud J. Fertility and sexuality of women with inflammatory arthritis. Eur J Obstet Gynecol Reprod Biol. 2020;251:199\u2013205. https:\/\/doi.org\/10.1016\/j.ejogrb.2020.05.068.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"877_CR49","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1093\/rheumatology\/41.12.1440","volume":"41","author":"JC Packham","year":"2002","unstructured":"Packham JC, Hall MA. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: social function, relationships and sexual activity. Rheumatology (Oxford). 2002;41:1440\u20133. https:\/\/doi.org\/10.1093\/rheumatology\/41.12.1440.","journal-title":"Rheumatology (Oxford)"},{"key":"877_CR50","first-page":"1783","volume":"27","author":"M Ostensen","year":"2000","unstructured":"Ostensen M, Almberg K, Koksvik HS. Sex, reproduction, and gynecological disease in young adults with a history of juvenile chronic arthritis. J Rheumatol. 2000;27:1783\u20137.","journal-title":"J Rheumatol"},{"key":"877_CR51","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1177\/0961203316658557","volume":"26","author":"K-J Kim","year":"2017","unstructured":"Kim K-J, Baek I-W, Park K-S, Kim W-U, Cho C-S. Association between antiphospholipid antibodies and arterial thrombosis in patients with rheumatoid arthritis. Lupus. 2017;26:88\u201394. https:\/\/doi.org\/10.1177\/0961203316658557.","journal-title":"Lupus"},{"key":"877_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2026.104836","volume":"173","author":"A Kontogiannis","year":"2026","unstructured":"Kontogiannis A, Papapanou M, Kalouta N, Syristatidi K, Siristatidis C. Outcomes of assisted reproductive technology in patients with immune-mediated rheumatic diseases: a systematic review and meta-analysis. J Reprod Immunol. 2026;173:104836. https:\/\/doi.org\/10.1016\/j.jri.2026.104836.","journal-title":"J Reprod Immunol"},{"key":"877_CR53","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/aogs.12324","volume":"93","author":"M Wallenius","year":"2014","unstructured":"Wallenius M, Salvesen K\u00c5, Daltveit AK, Skomsvoll JF. Rheumatoid arthritis and outcomes in first and subsequent births based on data from a national birth registry. Acta Obstet Gynecol Scand. 2014;93:302\u20137. https:\/\/doi.org\/10.1111\/aogs.12324.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"877_CR54","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/acr2.11447","volume":"4","author":"A Barnado","year":"2022","unstructured":"Barnado A, Hubbard J, Green S, Camai A, Wheless L, Osmundson S. Systemic lupus erythematosus delivery outcomes are unchanged across three decades. ACR Open Rheumatol. 2022;4:711\u201320. https:\/\/doi.org\/10.1002\/acr2.11447.","journal-title":"ACR Open Rheumatol"},{"key":"877_CR55","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/acr.23730","volume":"71","author":"CJF Smith","year":"2019","unstructured":"Smith CJF, F\u00f6rger F, Bandoli G, Chambers CD. Factors associated with preterm delivery among women with rheumatoid arthritis and women with juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2019;71:1019\u201327. https:\/\/doi.org\/10.1002\/acr.23730.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"877_CR56","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/annrheumdis-2016-210879","volume":"76","author":"K Remaeus","year":"2017","unstructured":"Remaeus K, Johansson K, Askling J, Stephansson O. Juvenile onset arthritis and pregnancy outcome: a population-based cohort study. Ann Rheum Dis. 2017;76:1809\u201314. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210879.","journal-title":"Ann Rheum Dis"},{"key":"877_CR57","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1097\/RHU.0000000000002123","volume":"30","author":"CH Siegel","year":"2024","unstructured":"Siegel CH, Sammaritano LR. Safety of medications used to treat autoimmune rheumatic diseases during pregnancy and lactation. J Clin Rheumatol. 2024;30:S25-33. https:\/\/doi.org\/10.1097\/RHU.0000000000002123.","journal-title":"J Clin Rheumatol"},{"key":"877_CR58","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.cgh.2012.11.011","volume":"11","author":"U Mahadevan","year":"2013","unstructured":"Mahadevan U, Wolf DC, Dubinsky M, et al. Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2013;11:286\u201392. https:\/\/doi.org\/10.1016\/j.cgh.2012.11.011. (quiz e24).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"877_CR59","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1136\/annrheumdis-2021-221036","volume":"81","author":"N Ghalandari","year":"2022","unstructured":"Ghalandari N, Kemper E, Crijns IH, et al. Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy. Ann Rheum Dis. 2022;81:402\u20135. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221036.","journal-title":"Ann Rheum Dis"},{"key":"877_CR60","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","volume":"75","author":"C G\u00f6testam Skorpen","year":"2016","unstructured":"G\u00f6testam Skorpen C, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75:795\u2013810. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208840.","journal-title":"Ann Rheum Dis"},{"key":"877_CR61","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1093\/rheumatology\/keac551","volume":"62","author":"MD Russell","year":"2023","unstructured":"Russell MD, Dey M, Flint J, et al. British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford). 2023;62:e48-88. https:\/\/doi.org\/10.1093\/rheumatology\/keac551.","journal-title":"Rheumatology (Oxford)"},{"key":"877_CR62","unstructured":"U.S. Food and Drug Administration. FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later because they can result in low amniotic fluid. 2025. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-recommends-avoiding-use-nsaids-pregnancy-20-weeks-or-later-because-they-can-result-low-amniotic. Accessed 16 Dec 2025."},{"key":"877_CR63","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1345\/aph.1G428","volume":"40","author":"G Koren","year":"2006","unstructured":"Koren G, Florescu A, Costei AM, Boskovic R, Moretti ME. Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother. 2006;40:824\u20139. https:\/\/doi.org\/10.1345\/aph.1G428.","journal-title":"Ann Pharmacother"},{"key":"877_CR64","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/1753495X19847832","volume":"13","author":"R Pofi","year":"2020","unstructured":"Pofi R, Tomlinson JW. Glucocorticoids in pregnancy. Obstet Med. 2020;13:62\u20139. https:\/\/doi.org\/10.1177\/1753495X19847832.","journal-title":"Obstet Med"},{"key":"877_CR65","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1542\/peds.8.4.527","volume":"8","author":"FC Fraser","year":"1951","unstructured":"Fraser FC, Fainstat TD. Production of congenital defects in the off-spring of pregnant mice treated with cortisone; progress report. Pediatrics. 1951;8:527\u201333.","journal-title":"Pediatrics"},{"key":"877_CR66","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","volume":"62","author":"L Park-Wyllie","year":"2000","unstructured":"Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000;62:385\u201392. https:\/\/doi.org\/10.1002\/1096-9926(200012)62:6%3c385::AID-TERA5%3e3.0.CO;2-Z.","journal-title":"Teratology"},{"key":"877_CR67","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/MJT.0b013e3182491e02","volume":"21","author":"A-M Bay Bj\u00f8rn","year":"2014","unstructured":"Bay Bj\u00f8rn A-M, Ehrenstein V, Hundborg HH, Nohr EA, S\u00f8rensen HT, N\u00f8rgaard M. Use of corticosteroids in early pregnancy is not associated with risk of oral clefts and other congenital malformations in offspring. Am J Ther. 2014;21:73\u201380. https:\/\/doi.org\/10.1097\/MJT.0b013e3182491e02.","journal-title":"Am J Ther"},{"key":"877_CR68","doi-asserted-by":"publisher","unstructured":"ACOG Committee. ACOG Committee Opinion No. 776: immune modulating therapies in pregnancy and lactation. Obstetr Gynecol. 2019;133:e287. https:\/\/doi.org\/10.1097\/AOG.0000000000003176.","DOI":"10.1097\/AOG.0000000000003176"},{"key":"877_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00228-022-03416-w","volume":"79","author":"J Wei","year":"2023","unstructured":"Wei J, Xia F, Miao J, Wang T, Chen L, Yan X. The risk of congenital heart defects associated with corticosteroids use during the first trimester of pregnancy: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2023;79:1\u201311. https:\/\/doi.org\/10.1007\/s00228-022-03416-w.","journal-title":"Eur J Clin Pharmacol"},{"key":"877_CR70","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1080\/14767058.2019.1649392","volume":"34","author":"E Cai","year":"2021","unstructured":"Cai E, Czuzoj-Shulman N, Abenhaim HA. Maternal and fetal outcomes in pregnancies with long-term corticosteroid use. J Matern Fetal Neonatal Med. 2021;34:1797\u2013804. https:\/\/doi.org\/10.1080\/14767058.2019.1649392.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"877_CR71","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1002\/art.24914","volume":"60","author":"YA de Man","year":"2009","unstructured":"de Man YA, Hazes JMW, van der Heide H, et al. Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum. 2009;60:3196\u2013206. https:\/\/doi.org\/10.1002\/art.24914.","journal-title":"Arthritis Rheum"},{"key":"877_CR72","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/rheumatology\/kez405","volume":"59","author":"K Palmsten","year":"2020","unstructured":"Palmsten K, Bandoli G, Vazquez-Benitez G, et al. Oral corticosteroid use during pregnancy and risk of preterm birth. Rheumatology (Oxford). 2020;59:1262\u201371. https:\/\/doi.org\/10.1093\/rheumatology\/kez405.","journal-title":"Rheumatology (Oxford)"},{"key":"877_CR73","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/pds.4410","volume":"27","author":"K Palmsten","year":"2018","unstructured":"Palmsten K, Rolland M, Hebert MF, et al. Patterns of prednisone use during pregnancy in women with rheumatoid arthritis: daily and cumulative dose. Pharmacoepidemiol Drug Saf. 2018;27:430\u20138. https:\/\/doi.org\/10.1002\/pds.4410.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"877_CR74","doi-asserted-by":"publisher","first-page":"e1328","DOI":"10.1210\/clinem\/dgad547","volume":"109","author":"EMA Slob","year":"2024","unstructured":"Slob EMA, Termote JUM, Nijkamp JW, van der Kamp HJ, van den Akker ELT. Safety of antenatal predniso(lo)ne and dexamethasone on fetal, neonatal and childhood outcomes: a systematic review. J Clin Endocrinol Metab. 2024;109:e1328\u201335. https:\/\/doi.org\/10.1210\/clinem\/dgad547.","journal-title":"J Clin Endocrinol Metab"},{"key":"877_CR75","doi-asserted-by":"publisher","unstructured":"ACOG Committee. ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132:e44\u201352. https:\/\/doi.org\/10.1097\/AOG.0000000000002708.","DOI":"10.1097\/AOG.0000000000002708"},{"key":"877_CR76","first-page":"59","volume":"24","author":"I Cavazzana","year":"2006","unstructured":"Cavazzana I, Franceschini F, Quinzanini M, et al. Anti-Ro\/SSA antibodies in rheumatoid arthritis: clinical and immunologic associations. Clin Exp Rheumatol. 2006;24:59\u201364.","journal-title":"Clin Exp Rheumatol"},{"key":"877_CR77","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jacc.2020.05.045","volume":"76","author":"P Izmirly","year":"2020","unstructured":"Izmirly P, Kim M, Friedman DM, et al. Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA\/Ro-positive mothers. J Am Coll Cardiol. 2020;76:292\u2013302. https:\/\/doi.org\/10.1016\/j.jacc.2020.05.045.","journal-title":"J Am Coll Cardiol"},{"key":"877_CR78","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1002\/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C","volume":"44","author":"A Brucato","year":"2001","unstructured":"Brucato A, Frassi M, Franceschini F, et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro\/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum. 2001;44:1832\u20135. https:\/\/doi.org\/10.1002\/1529-0131(200108)44:8%3c1832::AID-ART320%3e3.0.CO;2-C.","journal-title":"Arthritis Rheum"},{"key":"877_CR79","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/s41467-023-37427-7","volume":"14","author":"N Alata Jimenez","year":"2023","unstructured":"Alata Jimenez N, Castellano M, Santillan EM, , et al. Paternal methotrexate exposure affects sperm small RNA content and causes craniofacial defects in the offspring. Nat Commun. 2023;14:1617. https:\/\/doi.org\/10.1038\/s41467-023-37427-7.","journal-title":"Nat Commun"},{"key":"877_CR80","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/17425255.2017.1230198","volume":"13","author":"JC Gutierrez","year":"2017","unstructured":"Gutierrez JC, Hwang K. The toxicity of methotrexate in male fertility and paternal teratogenicity. Expert Opin Drug Metab Toxicol. 2017;13:51\u20138. https:\/\/doi.org\/10.1080\/17425255.2017.1230198.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"877_CR81","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1093\/rheumatology\/keab894","volume":"61","author":"K Hellgren","year":"2022","unstructured":"Hellgren K, Secher AE, Glintborg B, et al. Pregnancy outcomes in relation to disease activity and anti-rheumatic treatment strategies in women with rheumatoid arthritis: a matched cohort study from Sweden and Denmark. Rheumatology (Oxford). 2022;61:3711\u201322. https:\/\/doi.org\/10.1093\/rheumatology\/keab894.","journal-title":"Rheumatology (Oxford)"},{"key":"877_CR82","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1136\/annrheumdis-2012-202539","volume":"72","author":"FDO de Steenwinkel","year":"2013","unstructured":"de Steenwinkel FDO, Hokken-Koelega ACS, de Man YA, et al. Circulating maternal cytokines influence fetal growth in pregnant women with rheumatoid arthritis. Ann Rheum Dis. 2013;72:1995\u20132001. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202539.","journal-title":"Ann Rheum Dis"},{"key":"877_CR83","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.3109\/14767058.2015.1127342","volume":"29","author":"DS Atta","year":"2016","unstructured":"Atta DS, Girbash EF, Abdelwahab SM, Abdeldayem HM, Tharwat I, Ghonaim R. Maternal cytokines and disease severity influence pregnancy outcomes in women with rheumatoid arthritis. J Matern Fetal Neonatal Med. 2016;29:3358\u201363. https:\/\/doi.org\/10.3109\/14767058.2015.1127342.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"877_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-026-00663-7","author":"I Sagberg","year":"2026","unstructured":"Sagberg I, Skorpen CG, Lydersen S, et al. The biologic era and pregnancy in rheumatoid arthritis: a prospective multicenter study from the Norwegian RevNatus registry. BMC Rheumatol. 2026. https:\/\/doi.org\/10.1186\/s41927-026-00663-7.","journal-title":"BMC Rheumatol"},{"key":"877_CR85","doi-asserted-by":"publisher","first-page":"e2510504","DOI":"10.1001\/jamanetworkopen.2025.10504","volume":"8","author":"CLY Ewig","year":"2025","unstructured":"Ewig CLY, Wang Y, Smolinski NE, Thai TN, Rasmussen SA, Winterstein AG. Use of biologics during pregnancy among patients with autoimmune conditions. JAMA Netw Open. 2025;8:e2510504. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.10504.","journal-title":"JAMA Netw Open"},{"key":"877_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1269-1","volume":"19","author":"S van den Brandt","year":"2017","unstructured":"van den Brandt S, Zbinden A, Baeten D, Villiger PM, \u00d8stensen M, F\u00f6rger F. Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients. Arthritis Res Ther. 2017;19:64. https:\/\/doi.org\/10.1186\/s13075-017-1269-1.","journal-title":"Arthritis Res Ther"},{"key":"877_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.887462","volume":"13","author":"MC Gerardi","year":"2022","unstructured":"Gerardi MC, Crisafulli F, Garc\u00eda-Fernandez A, Lini D, Bazzani C, Cavazzana I, et al. Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis. Front Pharmacol. 2022;13:887462. https:\/\/doi.org\/10.3389\/fphar.2022.887462.","journal-title":"Front Pharmacol"},{"key":"877_CR88","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/art.40821","volume":"71","author":"F F\u00f6rger","year":"2019","unstructured":"F\u00f6rger F, Bandoli G, Luo Y, Robinson L, Johnson DL, Chambers CD. No association of discontinuing tumor necrosis factor inhibitors before gestational week twenty in well-controlled rheumatoid arthritis and juvenile idiopathic arthritis with a disease worsening in late pregnancy. Arthritis Rheumatol. 2019;71:901\u20137. https:\/\/doi.org\/10.1002\/art.40821.","journal-title":"Arthritis Rheumatol"},{"key":"877_CR89","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3899\/jrheum.180226","volume":"46","author":"H Jethwa","year":"2019","unstructured":"Jethwa H, Lam S, Smith C, Giles I. Does rheumatoid arthritis really improve during pregnancy? A systematic review and metaanalysis. J Rheumatol. 2019;46:245\u201350. https:\/\/doi.org\/10.3899\/jrheum.180226.","journal-title":"J Rheumatol"},{"key":"877_CR90","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/art.24003","volume":"59","author":"YA de Man","year":"2008","unstructured":"de Man YA, Dolhain RJEM, van de Geijn FE, Willemsen SP, Hazes JMW. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum. 2008;59:1241\u20138. https:\/\/doi.org\/10.1002\/art.24003.","journal-title":"Arthritis Rheum"},{"key":"877_CR91","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1080\/14397595.2020.1829342","volume":"31","author":"E Nakamura","year":"2021","unstructured":"Nakamura E, Kotani T, Hiramatsu Y, et al. Simplified disease activity index and clinical disease activity index before and during pregnancy correlate with those at postpartum in patients with rheumatoid arthritis. Mod Rheumatol. 2021;31:809\u201316. https:\/\/doi.org\/10.1080\/14397595.2020.1829342.","journal-title":"Mod Rheumatol"},{"key":"877_CR92","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/ar3227","volume":"13","author":"V Jain","year":"2011","unstructured":"Jain V, Gordon C. Managing pregnancy in inflammatory rheumatological diseases. Arthritis Res Ther. 2011;13:206. https:\/\/doi.org\/10.1186\/ar3227.","journal-title":"Arthritis Res Ther"},{"key":"877_CR93","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/978-3-319-59680-8_137","volume-title":"Consults in obstetric anesthesiology","author":"S Rajagopalan","year":"2018","unstructured":"Rajagopalan S. Rheumatoid arthritis in pregnancy. In: Mankowitz SKW, editor. Consults in obstetric anesthesiology. Cham: Springer International Publishing; 2018. p. 511\u20133. https:\/\/doi.org\/10.1007\/978-3-319-59680-8_137."},{"key":"877_CR94","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/acr.23724","volume":"71","author":"M Birru Talabi","year":"2019","unstructured":"Birru Talabi M, Clowse MEB, Blalock SJ, Moreland L, Siripong N, Borrero S. Contraception use among reproductive-age women with rheumatic diseases. Arthritis Care Res (Hoboken). 2019;71:1132\u201340. https:\/\/doi.org\/10.1002\/acr.23724.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"877_CR95","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-026-06074-8","volume":"46","author":"MC Gerardi","year":"2026","unstructured":"Gerardi MC, Gagliardi C, Giacobbe E, et al. Suboptimal contraceptive counseling and use in women with autoimmune rheumatic diseases of childbearing age: findings from a cross-sectional survey of patients. Rheumatol Int. 2026;46:42. https:\/\/doi.org\/10.1007\/s00296-026-06074-8.","journal-title":"Rheumatol Int"},{"key":"877_CR96","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2022-000823","volume":"9","author":"S Chandramouli","year":"2022","unstructured":"Chandramouli S, Alvarez C, Englund TR, Silverstein RG, Sheikh SZ. Teratogenic medication use associated with favourable odds of contraception counselling in a cohort of women with systemic lupus erythematosus at a large tertiary academic medical centre. Lupus Sci Med. 2022;9:e000823. https:\/\/doi.org\/10.1136\/lupus-2022-000823.","journal-title":"Lupus Sci Med"},{"key":"877_CR97","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.contraception.2021.08.017","volume":"105","author":"RG Silverstein","year":"2022","unstructured":"Silverstein RG, Fitz V, Thornton M, Carter A, Morse JE. Contraceptive use and counseling in patients with systemic lupus erythematosus. Contraception. 2022;105:46\u201350. https:\/\/doi.org\/10.1016\/j.contraception.2021.08.017.","journal-title":"Contraception"},{"key":"877_CR98","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.contraception.2010.02.003","volume":"82","author":"SL Farr","year":"2010","unstructured":"Farr SL, Folger SG, Paulen ME, Curtis KM. Safety of contraceptive methods for women with rheumatoid arthritis: a systematic review. Contraception. 2010;82:64\u201371. https:\/\/doi.org\/10.1016\/j.contraception.2010.02.003.","journal-title":"Contraception"},{"key":"877_CR99","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/acr.24249","volume":"73","author":"T Wolgemuth","year":"2021","unstructured":"Wolgemuth T, Stransky OM, Chodoff A, Kazmerski TM, Clowse MEB, Talabi MB. Exploring the preferences of women regarding sexual and reproductive health care in the rheumatology context: a qualitative study. Arthritis Care Res (Hoboken). 2021;73:1194\u2013200. https:\/\/doi.org\/10.1002\/acr.24249.","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-026-00877-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-026-00877-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-026-00877-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:28:56Z","timestamp":1790681336000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-026-00877-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":99,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["877"],"URL":"https:\/\/doi.org\/10.1007\/s40744-026-00877-8","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"27 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Noel L. Ermer and Lisa R. Sammaritano have nothing to disclose. Caroline H. Siegel has received honoraria from the Broth Agency and has served as a consultant for Bristol Myers Squibb.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}